How are LABX strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the LABX strangle priced from the September 29, 2026 end-of-day chain at a 30-day expiry (ATM IV 169.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$332.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a LABX strangle?

The breakeven for the LABX strangle priced on this page is roughly $10.68 and $19.33 at expiration, derived from the September 29, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LABX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 48.65%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current LABX implied volatility affect this strangle?

LABX ATM IV is at 169.70% with IV rank near 20.25%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

LABX Strangle Strategy

LABX (Investment Managers Series Trust II -Tradr 2X Long ALAB Daily ETF), in the Financial Services sector, (Asset Management industry), listed on CBOE.

LABX is a short-term tactical tool that aims to deliver twice (200%) the daily performance of Astera Labs Inc. (ALAB), before fees and expenses. The fund primarily enters into total return swap agreements with major global financial institutions that mirror ALABs daily returns. In case swaps are unavailable or less efficient, the fund may use FLEX call options or directly hold ALAB stock. Purchasers holding shares for longer than a day will need to monitor and rebalance their position frequently to attempt to achieve the 2x multiple. Purchasers should conduct their own individual stock research prior to initiating a position and trade with conviction. Due to the complexities of the product, shares tend to perform as anticipated only when the underlying shares are trending and holders are on the positive corresponding side of that trade.

LABX (Investment Managers Series Trust II -Tradr 2X Long ALAB Daily ETF) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $87.3M, a beta of 16.11 versus the broader market, a 52-week range of 2-39.04167, average daily share volume of 1.3M, a public-listing history dating back to 2025. These structural characteristics shape how LABX etf options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 16.11 indicates LABX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a strangle on LABX?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

LABX snapshot

As of September 29, 2026, spot at $15.18, ATM IV 169.70%, IV rank 20.25%, expected move 48.65%. The strangle on LABX below is built from the September 29, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this strangle structure on LABX specifically: LABX IV at 169.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a LABX strangle, with a market-implied 1-standard-deviation move of approximately 48.65% (roughly $7.39 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LABX expiries trade a higher absolute premium for lower per-day decay. Position sizing on LABX should anchor to the underlying notional of $15.18 per share and to the trader's directional view on LABX etf.

LABX strangle setup

The LABX strangle below is built from the September 29, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LABX at $15.18 on that close, the first option leg uses a $16.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LABX chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LABX shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$16.00	$1.95
Buy 1	Put	$14.00	$1.38

LABX strangle risk and reward

Net Premium / Debit: -$332.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$332.50
Breakeven(s): $10.68, $19.33
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

LABX strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on LABX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	+$1,066.50
$3.37	-77.8%	+$730.97
$6.72	-55.7%	+$395.44
$10.08	-33.6%	+$59.92
$13.43	-11.5%	-$275.61
$16.79	+10.6%	-$253.86
$20.14	+32.7%	+$81.67
$23.50	+54.8%	+$417.19
$26.85	+76.9%	+$752.72
$30.21	+99.0%	+$1,088.25

When traders use strangle on LABX

Strangles on LABX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the LABX chain.

LABX thesis for this strangle

The market-implied 1-standard-deviation range for LABX extends from approximately $7.79 on the downside to $22.57 on the upside. A LABX long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current LABX IV rank near 20.25% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LABX at 169.70%. As a Financial Services name, LABX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LABX-specific events.

LABX strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LABX positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LABX alongside the broader basket even when LABX-specific fundamentals are unchanged. Always rebuild the position from current LABX chain quotes before placing a trade.

Frequently asked questions

What is a strangle on LABX?: A strangle on LABX is the strangle strategy applied to LABX (etf). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With LABX etf at $15.18 on the September 29, 2026 close, the strikes shown on this page are snapped to the nearest listed LABX chain strike and the premiums come straight from that session's bid/ask midpoint.
How are LABX strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the LABX strangle priced from the September 29, 2026 end-of-day chain at a 30-day expiry (ATM IV 169.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$332.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a LABX strangle?: The breakeven for the LABX strangle priced on this page is roughly $10.68 and $19.33 at expiration, derived from the September 29, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LABX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 48.65%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on LABX?: Strangles on LABX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the LABX chain.
How does current LABX implied volatility affect this strangle?: LABX ATM IV is at 169.70% with IV rank near 20.25%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.